Article info
PDFSjögren’s syndrome
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
- Correspondence to Dr Jacques-Eric Gottenberg, Hopital de Hautepierre, Strasbourg 67000, France; jacques-eric.gottenberg{at}chru-strasbourg.fr
Citation
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
Publication history
- Received June 30, 2020
- Revised September 28, 2020
- Accepted September 30, 2020
- First published November 18, 2020.
Online issue publication
March 06, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.